SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Library > Live Supplier Webinar

A Case Study of the Development, Technical Transfer, and Scale-Up of a Lyophilized Antibody-Drug Conjugate Formulation

01-Jun-2017
10am CDT (Chicago)
Format: Webinar | Document type: Supplier Webinar
A Case Study of the Development, Technical Transfer, and Scale-Up of a Lyophilized Antibody-Drug Conjugate Formulation

Antibody-drug conjugates (ADCs) were developed to target the delivery of chemotherapeutic agents and greatly reduce the quantity of chemotherapeutic agent delivered to the patient. These two advantages have increased the interest of the medical community in their use and have greatly increased the number of molecules being investigated. The challenges include aggregation and loss of the chemotherapeutic agent due to the processing conditions.

This presentation is a case study in the formulation and process development, technical transfer, and scale-up of a lyophilized ADC.

Speakers:

  • Dörthe Pohlmann, CAPM

    Dörthe Pohlmann, CAPM

    Project Assistant/ Lab Specialist, Business Development Contract Manufacturing

    Baxter BioPharma Solutions

  • Gregory A. Sacha Ph.D.

    Gregory A. Sacha Ph.D.

    Senior Research Scientist

    Baxter BioPharma Solutions

Supplier's Info Centre

Baxter's BioPharma Solutions